Health-related quality of life in patients with newly diagnosed advanced ovarian cancer treated with niraparib vs placebo: Results from the phase 3 randomized PRIMA/ENGOT-OV26/GOG-3012 trial

1. Pothuri, B.
2. Han, S.
3. Chase, D.M.
4. Heitz, F.
5. Burger, R.A.
6. Gaba, L.
7. Van Le, L.
8. Guerra, E.
9. Bender, D.
10. Korach, J.
11. Cloven, N.
12. Churruca, C.
13. Follana, P.
14. DiSilvestro, P.
15. Baurain, J.-F.
16. Jardon, K.
17. Pisano, C.
18. Peen, U.
19. Mäenpää, J.
20. Gupta, D.
21. Bacqué, E.
22. Li, Y.
23. Compton, N.
24. Antonova, J.
25. Monk, B.J.
26. González-Martín, A.
27. Show all authors +

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1016/J.YGYNO.2024.01.021 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus